Cost inflation takes its toll, for now
Cost inflation delays margin recovery. Persistent input cost inflation, driven by sustained...
Read moreMeeting and maintaining guidance
H1 27 results were in line with pre-close guidance, with revenue up 18.7% and EBIT up 12.4% to...
Read morePremium focus delivers 6% H127 profit growth
Knights’ H1 FY27 trading update shows the strength of its strategy to focus on premium, more...
Read moreDiversified strategy delivers 15% H127 profit growth
BTG Consulting has delivered another excellent performance with H127 revenue rising c.11% and Adj....
Read moreClear commercial progress in challenging markets
Revenue and EBITDA ahead year on year: Group revenue rose by 3.1% in H1 FY27, or 5.7% for Hire and...
Read morePositive momentum with scope for outperformance
Restore’s update for the 10 months to 31 October confirms the strong H1 performance has continued,...
Read moreEuropean Marketing Authorisation Application for ECOVAXXIN® MG
ECO Animal Health Group has announced that it has submitted a Marketing Authorisation Application...
Read moreGrowth powers exceptional H1 results, strong start to H2
Assets under management and influence (AUM/I) grew 15.5% over H1 to £28.0bn, driven by strong...
Read moreChina weakness but profitability maintained
In a trading update for the six months to 30 September, ECO Animal Health reports revenue of...
Read moreNew venture growth mandate boosts fee prospects
IP Group has been appointed by Aberdeen Investments to manage a UK venture growth portfolio, via...
Read more- Prev
- 1 of 119 pages
- Next
